comparemela.com

Latest Breaking News On - Innovestor life science fund - Page 1 : comparemela.com

Neurodegenerative disease focused Teitur Trophics raises €28m in Series A financing

Teitur Trophics, a startup looking to prevent the death of neurons in neurodegenerative diseases, has completed a €28m (US$29.9m) Series A financing round co-led by Sunstone Life Science Ventures and Sound Bioventures.

Teitur trophicsBioinnovation instituteInnovestor life science fundAarhus universityLife science fundMarkets amp regulationsNeurodegenerative diseasesHuntingtons diseaseParkinson 039s disease

Teitur Trophics Raises EUR 28M in Series A Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Mathias ollendorffSimon molgaardCasper breumAnders dalbyFredrik lehmannSimon glerupMilla koistinahoTeitur trophicsInnovestor life science fundSunstone life science venturesSound bioventuresLife science fundCharles largeSusanne stuffersTeitur boardFrontotemporal dementia

Teitur Trophics Raises EUR 28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases

Financing co-led by Sunstone Life Science Ventures and Sound Bioventures with participation from Industrifonden, Innovestor's Life Science Fund and P53 InvestDiscovery of a novel mechanism with

United statesDennis riedlMathias ollendorffSimon molgaardCasper breumSimon glerupAnders dalbyFredrik lehmannMilla koistinahoPrnewswire teitur trophicsTeitur trophicsBioinnovation instituteIndustrifonden is sweden venture capital fundInnovestor life science fundAarhus universitySunstone life science ventures

HVR CARDIO CLOSES ON $11 Million SERIES B FINANCING WITH FINLAND S INNOVESTOR LIFE SCIENCE FUND AND TESI

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesEteläuomen läiTom flemingTim girtonHvr cardio announces new leadership team withInnovestor life science fundBoston scientificTech incStructural heartSeriesb roundChief executive officerStructural heart valveChief technology officerAnnuloplasty systemStructural heart physiciansHuman clinical

HVR Cardio raises $11 1M Series B

HVR Cardio announced that it closed a Series B round of financing worth €10.7 million ($11.1 million) in proceeds.

United statesEteläuomen läiTom flemingTim girtonInnovestor life science fundBoston scientificPekka simula

vimarsana © 2020. All Rights Reserved.